Lower rather than higher levels of B-type natriuretic peptides (NT-Pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with Nesiritide

Wayne L. Miller, John C Jr. Burnett, Karen A. Hartman, Michael P. Henle, Mary F. Burritt, Allan S Jaffe

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Elevated plasma natriuretic peptides in heart failure (HF) usually indicate a poor outcome and low levels a compensated state. In advanced chronic HF, however, low levels may reflect an impaired neurohormonal response. To assess this hypothesis, this study analyzed whether N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) and B-type natriuretic peptide (BNP) levels were related to mortality in 40 patients treated for decompensated chronic HF. Cardiovascular mortality during follow-up (10 ± 1 months) was 40%. BNP levels were lower in patients who died (487 ± 60 vs 836 ± 99 pg/ml, p <0.02), as were NT-pro-BNP levels (9,507 ± 1,178 vs 17,611 ± 4,338 pg/ml, p <0.05). These data support the hypothesis that patients with end-stage HF and poor short-term survival have lower natriuretic peptide levels than those who survive. These findings suggest that the natriuretic peptide system can no longer contribute adequately to neurohormonal compensation and that paradoxically low peptide levels are an adverse prognostic marker in advanced HF.

Original languageEnglish (US)
Pages (from-to)837-841
Number of pages5
JournalAmerican Journal of Cardiology
Volume96
Issue number6
DOIs
StatePublished - Sep 15 2005

Fingerprint

Brain Natriuretic Peptide
Heart Failure
Natriuretic Peptides
Mortality
peptide B
Peptides
Survival

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Lower rather than higher levels of B-type natriuretic peptides (NT-Pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with Nesiritide. / Miller, Wayne L.; Burnett, John C Jr.; Hartman, Karen A.; Henle, Michael P.; Burritt, Mary F.; Jaffe, Allan S.

In: American Journal of Cardiology, Vol. 96, No. 6, 15.09.2005, p. 837-841.

Research output: Contribution to journalArticle

@article{5ccbbb203f9e4173ae8ee53f98e34786,
title = "Lower rather than higher levels of B-type natriuretic peptides (NT-Pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with Nesiritide",
abstract = "Elevated plasma natriuretic peptides in heart failure (HF) usually indicate a poor outcome and low levels a compensated state. In advanced chronic HF, however, low levels may reflect an impaired neurohormonal response. To assess this hypothesis, this study analyzed whether N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) and B-type natriuretic peptide (BNP) levels were related to mortality in 40 patients treated for decompensated chronic HF. Cardiovascular mortality during follow-up (10 ± 1 months) was 40{\%}. BNP levels were lower in patients who died (487 ± 60 vs 836 ± 99 pg/ml, p <0.02), as were NT-pro-BNP levels (9,507 ± 1,178 vs 17,611 ± 4,338 pg/ml, p <0.05). These data support the hypothesis that patients with end-stage HF and poor short-term survival have lower natriuretic peptide levels than those who survive. These findings suggest that the natriuretic peptide system can no longer contribute adequately to neurohormonal compensation and that paradoxically low peptide levels are an adverse prognostic marker in advanced HF.",
author = "Miller, {Wayne L.} and Burnett, {John C Jr.} and Hartman, {Karen A.} and Henle, {Michael P.} and Burritt, {Mary F.} and Jaffe, {Allan S}",
year = "2005",
month = "9",
day = "15",
doi = "10.1016/j.amjcard.2005.05.032",
language = "English (US)",
volume = "96",
pages = "837--841",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Lower rather than higher levels of B-type natriuretic peptides (NT-Pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with Nesiritide

AU - Miller, Wayne L.

AU - Burnett, John C Jr.

AU - Hartman, Karen A.

AU - Henle, Michael P.

AU - Burritt, Mary F.

AU - Jaffe, Allan S

PY - 2005/9/15

Y1 - 2005/9/15

N2 - Elevated plasma natriuretic peptides in heart failure (HF) usually indicate a poor outcome and low levels a compensated state. In advanced chronic HF, however, low levels may reflect an impaired neurohormonal response. To assess this hypothesis, this study analyzed whether N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) and B-type natriuretic peptide (BNP) levels were related to mortality in 40 patients treated for decompensated chronic HF. Cardiovascular mortality during follow-up (10 ± 1 months) was 40%. BNP levels were lower in patients who died (487 ± 60 vs 836 ± 99 pg/ml, p <0.02), as were NT-pro-BNP levels (9,507 ± 1,178 vs 17,611 ± 4,338 pg/ml, p <0.05). These data support the hypothesis that patients with end-stage HF and poor short-term survival have lower natriuretic peptide levels than those who survive. These findings suggest that the natriuretic peptide system can no longer contribute adequately to neurohormonal compensation and that paradoxically low peptide levels are an adverse prognostic marker in advanced HF.

AB - Elevated plasma natriuretic peptides in heart failure (HF) usually indicate a poor outcome and low levels a compensated state. In advanced chronic HF, however, low levels may reflect an impaired neurohormonal response. To assess this hypothesis, this study analyzed whether N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) and B-type natriuretic peptide (BNP) levels were related to mortality in 40 patients treated for decompensated chronic HF. Cardiovascular mortality during follow-up (10 ± 1 months) was 40%. BNP levels were lower in patients who died (487 ± 60 vs 836 ± 99 pg/ml, p <0.02), as were NT-pro-BNP levels (9,507 ± 1,178 vs 17,611 ± 4,338 pg/ml, p <0.05). These data support the hypothesis that patients with end-stage HF and poor short-term survival have lower natriuretic peptide levels than those who survive. These findings suggest that the natriuretic peptide system can no longer contribute adequately to neurohormonal compensation and that paradoxically low peptide levels are an adverse prognostic marker in advanced HF.

UR - http://www.scopus.com/inward/record.url?scp=24944542335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944542335&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2005.05.032

DO - 10.1016/j.amjcard.2005.05.032

M3 - Article

C2 - 16169373

AN - SCOPUS:24944542335

VL - 96

SP - 837

EP - 841

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 6

ER -